Angle Health raises $200M Series C, reaches $2.7B valuation
Angle Health, a Y Combinator-backed startup, announced a $200 million Series C and a $400 million tender offer at a $2.7 billion valuation. The company helps small businesses manage level-funded health plans and says it serves over 5,000 customers while being profitable. The round was led by Vitruvian Partners with participation from existing investors.
The financing includes a significant secondary component, allowing early employees and investors to liquidate holdings while the primary capital supports growth initiatives. Vitruvian Partners led the round, with participation from existing backers including Town Hall Ventures, Blumberg Capital, Portage Ventures, PruVen Capital, and Y Combinator. The company projects the round will officially close later this month.
Angle Health operates in the niche between traditional fully insured and self-funded insurance models. Its platform leverages AI to assist small businesses with plan selection and administration, integrating with existing payroll and HR infrastructure. The startup claims profitability while serving over 5,000 business clients, a notable achievement in the capital-intensive health insurance sector.
This funding could signal renewed investor confidence in health tech startups beyond the current AI agent boom. If Angle Health's model proves scalable, it may pressure traditional insurers to offer more flexible, cost-transparent options for small businesses, potentially lowering healthcare costs for thousands of employers and their workers. However, the tender offer structure suggests early investors are seeking liquidity, which could indicate a longer path to IPO or acquisition in the heavily regulated insurance market.